Concepedia

Tomasz Sewastianik

TS

Statistics

Publications

6

Citations

227

H-Index

6

Active since

2016

Affiliations

Instytut Hematologii i Transfuzjologi(Current)

Postgraduate School of Molecular Medicine

Collegium Civitas

The Maria Sklodowska-Curie National Research Institute of Oncology

Tomasz Sewastianik is an author at Instytut Hematologii i Transfuzjologi specializing in oncology, molecular oncology, and life sciences.

Publications per year

2016–2018

6

Publications

6

FOXO1 activation is an effector of SYK and AKT inhibition in tonic BCR signal-dependent diffuse large B-cell lymphomas

Maciej Szydłowski, Przemysław Kiliszek, Tomasz Sewastianik et al. · Blood · 2016 · 65 citations · Full text

, , +13

Expression of PIM kinases in Reed-Sternberg cells fosters immune privilege and tumor cell survival in Hodgkin lymphoma

Maciej Szydłowski, Monika Prochorec‐Sobieszek, Anna Szumera‐Ciećkiewicz et al. · Blood · 2017 · 52 citations · Full text

, , +11

MEK Inhibition Sensitizes Precursor B-Cell Acute Lymphoblastic Leukemia (B-ALL) Cells to Dexamethasone through Modulation of mTOR Activity and Stimulation of Autophagy

Anna Polak, Przemysław Kiliszek, Tomasz Sewastianik et al. · PLoS ONE · 2016 · 37 citations · Full text

, , +17

A novel, dual pan-PIM/FLT3 inhibitor SEL24 exhibits broad therapeutic potential in acute myeloid leukemia

Wojciech Czardybon, Renata Windak, Aniela Gołas et al. · Oncotarget · 2018 · 36 citations · Full text

, , +14

Microenvironment‐induced <scp>PIM</scp> kinases promote <scp>CXCR</scp>4‐triggered <scp>mTOR</scp> pathway required for chronic lymphocytic leukaemia cell migration

Emilia Białopiotrowicz, Patryk Górniak, Monika Noyszewska‐Kania et al. · Journal of Cellular and Molecular Medicine · 2018 · 20 citations · Full text

, , +13

1–5 of 6